Coronavirus Update: Pfizer seeks FDA nod for vaccine for children as young as 6 months, and latest studies find omicron may not protect against future infection

Pfizer and BioNTech asked federal regulators Tuesday to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months, and the first shots could come by the end of February.

Pfizer and BioNTech asked federal regulators Tuesday to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months, and the first shots could come by the end of February.